Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001326190-25-000019
Filing Date
2025-02-27
Accepted
2025-02-27 16:49:48
Documents
15

Document Format Files

Seq Description Document Type Size
1 S-3 tmb-20250227xs3.htm S-3 522362
2 EX-1.2 tmb-20250227xex1d2.htm EX-1.2 297955
3 EX-4.4 tmb-20250227xex4d4.htm EX-4.4 756479
4 EX-4.5 tmb-20250227xex4d5.htm EX-4.5 760513
5 EX-5.5 tmb-20250227xex5d5.htm EX-5.5 26152
6 EX-5.2 tmb-20250227xex5d2.htm EX-5.2 16681
7 EX-23.1 tmb-20250227xex23d1.htm EX-23.1 2596
8 EX-FILING FEES tmb-20250227xexfees.htm EX-FILING FEES 78432
9 GRAPHIC tmb-20250227xex5d2001.jpg GRAPHIC 5708
10 GRAPHIC tmb-20250227xex5d5001.jpg GRAPHIC 5832
11 GRAPHIC tmb-20250227xs3007.jpg GRAPHIC 11786
12 GRAPHIC tmb-20250227xs3009.jpg GRAPHIC 70088
13 GRAPHIC tmb-20250227xs3010.jpg GRAPHIC 134691
14 GRAPHIC tmb-20250227xs3015.jpg GRAPHIC 8005
15 GRAPHIC tmb-20250227xs3021.jpg GRAPHIC 11287
  Complete submission text file 0001326190-25-000019.txt   2804214
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-285355 | Film No.: 25680216
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)